CSTONE PHARMACEUTICALS revenue breakdown overview

CSTONE PHARMACEUTICALS revenue for the last year amounted to 65.33 M USD, the most of which — 65.62 M USD — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 71.66 M USD. The greatest contribution to the revenue figure was made by China (excluding Hong Kong and Taiwan) — last year it brought CSTONE PHARMACEUTICALS 52.38 M USD, and the year before that — 70.94 M USD.